These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Recent Updates in Melanocyte Function: The Use of Promising Bioactive Compounds for the Treatment of Hypopigmentary Disorders. Ali SA; Naaz I; Zaidi KU; Ali AS Mini Rev Med Chem; 2017; 17(9):785-798. PubMed ID: 28019642 [TBL] [Abstract][Full Text] [Related]
23. The melanocyte and the epidermal melanin unit: an expanded concept. Nordlund JJ Dermatol Clin; 2007 Jul; 25(3):271-81, vii. PubMed ID: 17662893 [TBL] [Abstract][Full Text] [Related]
24. Melanocytogenesis and melanogenesis: genetic regulation and comparative clinical diseases. Alhaidari ; Olivry ; Ortonne Vet Dermatol; 1999 Mar; 10(1):3-16. PubMed ID: 34644972 [TBL] [Abstract][Full Text] [Related]
26. [Silvery hair in children: a symptom of leucogranulocytic and melanocytic diseases (author's transl)]. Larrègue M; Buriot D; Prigent F; Lorette G; Marié M; Degos R Ann Dermatol Venereol; 1981; 108(4):329-34, 337-40. PubMed ID: 7258987 [TBL] [Abstract][Full Text] [Related]
27. [The main etiopathogenic mechanisms of neurocutaneous diseases]. Vicente FJ; Gil P; Vázquez-Doval FJ Rev Neurol; 1997 Sep; 25 Suppl 3():S214-21. PubMed ID: 9273165 [TBL] [Abstract][Full Text] [Related]
28. Melanocytes and their diseases. Yamaguchi Y; Hearing VJ Cold Spring Harb Perspect Med; 2014 May; 4(5):. PubMed ID: 24789876 [TBL] [Abstract][Full Text] [Related]
29. The developmental biology of melanocytes and its application to understanding human congenital disorders of pigmentation. Hornyak TJ Adv Dermatol; 2006; 22():201-18. PubMed ID: 17249303 [TBL] [Abstract][Full Text] [Related]
30. Mechanisms of hypopigmentation in human oculocutaneous albinism. King RA; Olds DP; Townsend D Prog Clin Biol Res; 1988; 256():183-91. PubMed ID: 3285349 [TBL] [Abstract][Full Text] [Related]
31. Advances in inherited disorders of hypopigmentation: comparisons of mice and men. Bloom KE Curr Opin Pediatr; 1993 Aug; 5(4):458-63. PubMed ID: 8374674 [TBL] [Abstract][Full Text] [Related]
32. [Molecular basis of pigmentation disorders in skin diseases]. Drukała J; Bobis S; Zabińska-Płazak E; Wojas-Pelc A Przegl Lek; 2009; 66(3):145-9. PubMed ID: 19689040 [TBL] [Abstract][Full Text] [Related]
33. Clinical, laboratory and molecular signs of immunodeficiency in patients with partial oculo-cutaneous albinism. Dotta L; Parolini S; Prandini A; Tabellini G; Antolini M; Kingsmore SF; Badolato R Orphanet J Rare Dis; 2013 Oct; 8():168. PubMed ID: 24134793 [TBL] [Abstract][Full Text] [Related]
34. Congenital Sensorineural Hearing Loss and Inborn Pigmentary Disorders: First Report of Multilocus Syndrome in Piebaldism. Gironi LC; Colombo E; Brusco A; Grosso E; Naretto VG; Guala A; Di Gregorio E; Zonta A; Zottarelli F; Pasini B; Savoia P Medicina (Kaunas); 2019 Jul; 55(7):. PubMed ID: 31284637 [TBL] [Abstract][Full Text] [Related]
35. The actions of melanin and melanocyte stimulating hormone (MSH). Rasmussen N; Nelson F; Govitrapong P; Ebadi M Neuro Endocrinol Lett; 1999; 20(5):265-282. PubMed ID: 11460086 [TBL] [Abstract][Full Text] [Related]
36. Striking contiguous depigmentation across the lower limbs in piebaldism and its implications for understanding melanocytic migration and development. Funkhouser CH; Kinsler VA; Frieden IJ Pediatr Dermatol; 2019 Jul; 36(4):511-513. PubMed ID: 30983016 [TBL] [Abstract][Full Text] [Related]
37. Dyschromatosis universalis hereditaria: two cases in a Chinese family. Wang G; Li CY; Gao TW; Liu YF Clin Exp Dermatol; 2005 Sep; 30(5):494-6. PubMed ID: 16045675 [TBL] [Abstract][Full Text] [Related]
38. Role of the ubiquitin proteasome system in regulating skin pigmentation. Ando H; Ichihashi M; Hearing VJ Int J Mol Sci; 2009 Nov; 10(10):4428-4434. PubMed ID: 20057953 [TBL] [Abstract][Full Text] [Related]